LIVZON PHARMA - Summary table of non-operating fund occupation and other related fund transactions of Livzon Pharmaceutical Group Co., Ltd. for the first half of 2026
Overseas regulatory announcement
This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The "Summary Table of Non-operating Fund Occupation and Other Related Fund Transactions of Livzon Pharmaceutical Group Co., Ltd. for the 2026 Half Year" published by Livzon Pharmaceutical Group Co., Ltd. on the website of the Shenzhen Stock Exchange is hereby provided for reference only.
By order of the board of directors
Livzon Pharmaceutical Group Co., Ltd.
LivzonPharmaceuticalGroupInc.*
company secretary
Liu Ning
China, Zhuhai
August 21, 2026
As of the date of this announcement, the company’s executive directors are Mr. Liu Daping (president) and Mr. Tang Yanggang (vice chairman); the company’s non-executive directors are Mr. Zhu Baoguo (chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee directors are Ms. Ran Yongmei; and the company’s independent non-executive directors are Mr. Luo Huiyuan, Ms. Cui Lijie, Ms. Wang Zhiyao and Ms. Kang Li.
*Identification only
Summary table of non-operating fund occupation and other related fund transactions of Livzon Pharmaceutical Group Co., Ltd. from January to June 2026
Compilation unit: Livzon Pharmaceutical Group Co., Ltd. Amount unit: RMB 10,000
January-June 2026 January-June 2026 January-June 2026
June 2026
Accounting between the non-operating capital occupier and the listed company of the listed company. The accumulated monthly occupation of funds in the beginning of 2026 will be repaid in June.
Name of the party occupying the funds. Reason for the occupation on the 30th. Nature of occupation. Accounting account with associated relationship. Fund balance amount (excluding interest interest (such as cumulative occurrences).
Fund balance
Interest) has) amount
controlling shareholder, actual
international controller and its
Affiliates
Subtotal —— —— —— ——
former controlling shareholder,
actual controller and
its affiliated companies
Subtotal —— —— —— ——
other related parties and
Affiliates
Subtotal —— —— —— ——
Total —— —— —— —— —— January to June 2026 January 6, 2026 January 2026
June 2026
Accounting for listed companies between other related fund parties and listed companies. Cumulative monthly occupation of funds occupied at the beginning of 2026. Repayment in June
Name of the party that corresponds to the funds. The reason for the transaction on the 30th. The reason for the transaction. The nature of the transaction. The amount of the fund balance for the accounting account (excluding interest (excluding accumulated interest)).
Fund balance
Interest) has) amount
Notes receivable from a subsidiary of the controlling shareholder of Jiaozuo Joincare Bioproducts Co., Ltd. 18.08 18.08 Operating transactions for sales of products
Notes receivable from a subsidiary of the controlling shareholder of Joincare (Guangdong) Special Medical Food Co., Ltd. 13.94 13.93 13.94 13.93 Leasing, water, electricity and power operating transactions
Notes receivable from a subsidiary of the controlling shareholder of Joincare Haibin Pharmaceutical Co., Ltd. 249.00 147.66 282.06 114.60 Operating transactions for sales of products
Accounts receivable from a subsidiary of the controlling shareholder of Jiaozuo Joincare Bioproducts Co., Ltd. 1.05 1.05 Operating transactions for sales of products
Sales of products, research and development, processing
Accounts receivable from the controlling shareholder of Joincare Pharmaceutical Group Co., Ltd. 29.12 1,879.38 452.08 1,456.42 Operating transactions
Engineering, testing
Accounts receivable from subsidiaries of the controlling shareholder and the controlling shareholder of Shijianjiangyuan Haibin Pharmaceutical Co., Ltd. 81.60 340.26 165.06 256.80 Advance payments from the inter-controller and its controlling shareholder of the controlling shareholder of the Company for sales of products 41.78 36.92 4.86 Operating transactions from affiliated enterprises for the purchase of products
Other receivables from the controlling shareholder of Joincare Pharmaceutical Group Co., Ltd. 4.35 2.63 1.72 Operating transactions for purchasing products
Other receivables from subsidiaries of the controlling shareholder of Shenzhen Haibin Pharmaceutical Co., Ltd. 287.14 287.14 Operating transactions related to sales of fixed assets
Other receivables from subsidiaries of the controlling shareholder of Health Pharmaceutical (China) Co., Ltd. 0.30 0.30 Lease and operating transactions
Other receivables from a subsidiary of the controlling shareholder of Joincare (Guangdong) Special Medical Food Co., Ltd. 13.93 13.93 Leasing, water, electricity and power operating transactions
Other receivables from the subsidiary of the controlling shareholder of Jiaozuo Joincare Biological Products Co., Ltd. 287.14 -287.14 Operating transactions related to sales of fixed assets
Other receivables from subsidiaries of the controlling shareholder of Tiancheng Industrial Co., Ltd. 1.34 1.34 Lease operating transactions
January-June 2026 January-June 2026 January-June 2026
June 2026
Accounting for listed companies between other related fund parties and listed companies. Cumulative monthly occupation of funds occupied at the beginning of 2026. Repayment in June
Name of the party that corresponds to the funds. The reason for the transaction on the 30th. The reason for the transaction. The nature of the transaction. The amount of the fund balance for the accounting account (excluding interest (excluding accumulated interest)).
Fund balance
Interest) has) amount
Other receivables from subsidiaries of Zhuhai Lizhu MAB Biotechnology Co., Ltd. 1,723.99 628.01 323.59 2,028.41 Capital transactions for operating transactions Subsidiaries of listed companies
Other receivables of the company and its subsidiaries of Antao Development Co., Ltd. 10,236.49 1,253.43 1,343.55 10,146.37 Capital transactions with non-operating enterprises
Other receivables from subsidiaries of Macau (Livzon) Co., Ltd. 36.61 36.61 Capital transactions, non-operating transactions
Summary table of non-operating fund occupation and other related fund transactions of Livzon Pharmaceutical Group Co., Ltd. from January to June 2026. Preparation unit: Livzon Pharmaceutical Group Co., Ltd. Amount unit: RMB 10,000 Other receivables of subsidiaries of Livzon Group Vaccine Engineering Co., Ltd. 2,103.36 2,103.36 Capital transactions Non-operating transactions
Other receivables from subsidiaries of Zhuhai Livzon Reagent Co., Ltd. 1,498.72 1.28 1,500.00 Capital transactions, non-operating transactions, other related parties and non-operating transactions, its subsidiaries
Non-business transactions
Total —— —— 14,779.33 6,111.28 1.28 2,941.67 17,950.22 —— ——
This table was approved by the second meeting of the 12th Board of Directors on August 21, 2026.
Chairman and legal representative: Zhu Baoguo President: Liu Daping Person in charge of accounting work: Wang Sheng Person in charge of accounting department: Wang Sheng